secwatch / observer
8-K filed April 18, 2024, 7:59 PM ET ticker NEO CIK 0001077183
leadership confidence high sentiment neutral materiality 0.60

NeoGenomics eliminates President, Advanced Diagnostics role; promotes Harris and Stone

NEOGENOMICS INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Vishal Sikri

President, Advanced Diagnostics
NEO · NEOGENOMICS INC
Filed
April 18, 2024, 7:59 PM ET
as a result, Vishal Sikri, the current President, Advanced Diagnostics, will no longer hold such role
Role change

Melody Harris

Chief Operations Officer and President, Informatics
NEO · NEOGENOMICS INC
Filed
April 18, 2024, 7:59 PM ET
Melody Harris, presently the Company's President, Enterprise Operations will now serve as the Company's Chief Operations Officer and President, Informatics.
Role change

Warren Stone

Chief Commercial Officer
NEO · NEOGENOMICS INC
Filed
April 18, 2024, 7:59 PM ET
Warren Stone, presently the Company's President, Clinical Services will now serve as the Company's Chief Commercial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Vishal Sikri changed role as President, Advanced Diagnostics at NEOGENOMICS INC.

Action
will no longer hold such role
Role
President, Advanced Diagnostics
Exact text from the filing
as a result, Vishal Sikri, the current President, Advanced Diagnostics, will no longer hold such role
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Melody Harris changed role as Chief Operations Officer and President, Informatics at NEOGENOMICS INC.

Action
will now serve as
Role
Chief Operations Officer and President, Informatics
Exact text from the filing
Melody Harris, presently the Company's President, Enterprise Operations will now serve as the Company's Chief Operations Officer and President, Informatics.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Warren Stone changed role as Chief Commercial Officer at NEOGENOMICS INC.

Action
will now serve as
Role
Chief Commercial Officer
Exact text from the filing
Warren Stone, presently the Company's President, Clinical Services will now serve as the Company's Chief Commercial Officer.
View on SEC.gov

NEOGENOMICS INC filing history →

Source: SEC EDGAR
accession 0001077183-24-000048
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.